Brief: Eckert & Ziegler Signs Agreement For The Supply Of Lutetium-177 With Point Biopharma

POINT Biopharma Global

25/09/2023 22:20

Sept 25 (Reuters) - Eckert & Ziegler  EUZG.DE :
    * EQS-ADHOC: ECKERT & ZIEGLER SIGNS STRATEGICALLY IMPORTANT
AGREEMENT FOR THE SUPPLY OF LUTETIUM-177 WITH POINT BIOPHARMA
    * AGREEMENT HAS A TERM OF TEN YEARS WITH A TOTAL SALES
VOLUME OF
MORE THAN EUR 100 MILLION.
    * PLANS TO INVEST AROUND EUR 10 MILLION IN ITS OWN SITE IN
WILMINGTON
    * STRATEGICALLY SIGNIFICANT AGREEMENT IS EXPECTED TO START
CONTRIBUTING REVENUES IN 2023

Source text for Eikon:  ID:nEQ7dVd4fa 
Further company coverage:  EUZG.DE 

 ((Reuters.Briefs@thomsonreuters.com;))